المؤلفون: Costa, Bruno Marques, Caeiro, Cláudia, Guimarães, Inês, Martinho, Olga, Jaraquemada, Teresa, Augusto, Isabel, Castro, Lígia, Osório, Lígia, Linhares, Paulo, Honavar, Mrinalini, Resende, Mário, Braga, Fátima, Silva, Ana, Pardal, Fernando, Amorim, Júlia, Nabiço, Rui, Almeida, Rui, Alegria, Carlos, Pires, Manuel, Pinheiro, Célia, Carvalho, Ernesto, Lopes, José M., Costa, Paulo, Damasceno, Margarida, Reis, R. M.

مصطلحات موضوعية: Glioblastoma, Prognosis, MGMT methylation, Temozolomide, Chemoradiation, Science & Technology

وصف الملف: application/pdf

العلاقة: info:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F33612%2F2009/PT; http://www.spandidos-publications.com/or/23/6/1655Test; http://hdl.handle.net/1822/29360Test

الإتاحة: https://doi.org/10.3892/or_00000808Test
http://hdl.handle.net/1822/29360Test

المؤلفون: José Manuel Lopes, Mrinalini Honavar, Ernesto Carvalho, Paulo Linhares, Célia Pinheiro, Olga Martinho, Cláudia Caeiro, Lígia Castro, Carlos Alegria, Inês Guimarães, Manuel Melo Pires, Lígia Osório, Paulo Costa, Isabel Augusto, Teresa Jaraquemada, Rui Nabiço, Margarida Damasceno, Fernando Pardal, Fátima Braga, Bruno M. Costa, M. Resende, Ana M. G. Silva, Rui Almeida, Júlia Amorim, Rui Manuel Reis

المساهمون: Universidade do Minho

المصدر: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Europe PubMed Central

مصطلحات موضوعية: Male, Oncology, Cancer Research, Pathology, medicine.medical_specialty, Methyltransferase, Brain tumor, Antineoplastic Agents, O(6)-Methylguanine-DNA Methyltransferase, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Temozolomide, Humans, MGMT methylation, Promoter Regions, Genetic, Prospective cohort study, neoplasms, Survival analysis, 030304 developmental biology, 0303 health sciences, Science & Technology, Portugal, Brain Neoplasms, business.industry, Cancer, Radiotherapy Dosage, General Medicine, Methylation, DNA Methylation, Middle Aged, medicine.disease, Prognosis, Combined Modality Therapy, 3. Good health, Dacarbazine, Survival Rate, Treatment Outcome, Chemoradiation, 030220 oncology & carcinogenesis, Concomitant, Female, business, Glioblastoma, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09ff036aa9c0192b3e194e67a821642dTest
https://hdl.handle.net/1822/29360Test